Kathy L. Hibbs Sells 38,548 Shares of 23andMe Holding Co. (NASDAQ:ME) Stock

23andMe Holding Co. (NASDAQ:ME) insider Kathy L. Hibbs sold 38,548 shares of the firm’s stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $0.47, for a total value of $18,117.56. Following the sale, the insider now owns 1,252,315 shares in the company, valued at $588,588.05. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

23andMe Trading Down 4.5 %

ME stock traded down $0.02 during trading on Friday, reaching $0.48. The stock had a trading volume of 17,180,838 shares, compared to its average volume of 7,390,713. The firm has a fifty day moving average price of $0.54 and a 200 day moving average price of $0.73. The company has a market capitalization of $233.20 million, a P/E ratio of -0.46 and a beta of 1.27. 23andMe Holding Co. has a 1-year low of $0.35 and a 1-year high of $2.21.

23andMe (NASDAQ:ME) last announced its earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share (EPS) for the quarter. The business had revenue of $44.75 million for the quarter, compared to analysts’ expectations of $56.30 million. 23andMe had a negative return on equity of 52.99% and a negative net margin of 210.48%.

Hedge Funds Weigh In On 23andMe

Several institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of 23andMe by 3.1% in the third quarter. Vanguard Group Inc. now owns 28,145,216 shares of the company’s stock worth $27,518,000 after buying an additional 834,504 shares during the last quarter. BlackRock Inc. grew its holdings in 23andMe by 4.9% during the 2nd quarter. BlackRock Inc. now owns 19,330,109 shares of the company’s stock worth $33,828,000 after acquiring an additional 910,127 shares in the last quarter. State Street Corp increased its position in shares of 23andMe by 10.3% in the 2nd quarter. State Street Corp now owns 6,183,243 shares of the company’s stock worth $10,821,000 after purchasing an additional 576,924 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of 23andMe by 4.7% in the 2nd quarter. Geode Capital Management LLC now owns 5,617,120 shares of the company’s stock valued at $9,830,000 after purchasing an additional 254,321 shares in the last quarter. Finally, Voya Investment Management LLC raised its stake in shares of 23andMe by 127.0% in the 4th quarter. Voya Investment Management LLC now owns 5,517,344 shares of the company’s stock valued at $5,040,000 after purchasing an additional 3,086,866 shares in the last quarter. 36.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Citigroup dropped their price objective on shares of 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a research note on Tuesday.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.